FROM A-LEVELS OR AN OVERSEAS DEGREE TO PRACTISING IN THE UKSearch the guide
← All news
NEW MEDICINES AND DRUG DISCOVERY · FDA: DRUGS · 29 October 2026

Table of Surrogate Endpoints That Were the Basis of Drug Approval or Licensure

Synopsis

Table of Surrogate Endpoints That Were the Basis of Drug Approval or Licensure What is the purpose of the Surrogate Endpoint Table? Traditional Mechanism agnostic* *Mechanism agnostic refers to cases where there are many mechanisms of action associated with a surrogate endpoint, so it is not directly related to a particular causal pathway.

Automatically extracted from the original page. This is a short summary, not the full story, and may omit important detail.

Read the full story at FDA: drugs ↗

More in New medicines and drug discovery